Sector: Health Care.Industry: Biotechnology
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-10 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.700 | -0.850 | -0.1500 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PASG | Passage Bio | 2.06% | 1.1B |
Passage Bio Company Questions & Answers
Q
How do I buy Passage Bio (PASG) stock?
A
You can purchase shares of Passage Bio (NASDAQ: PASG) through any online brokerage.
Q
Who are Passage Bio's (PASG) main competitors?
A
Other companies in Passage Bio’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Trillium Therapeutics (NASDAQ:TRIL) and Syndax Pharmaceuticals (NASDAQ:SNDX).
Q
What is the target price for Passage Bio?
A
The latest price target for Passage Bio (NASDAQ: PASG) was reported by Goldman Sachs on 2021-03-04. The analyst firm set a price target for 30.00 expecting PASG to rise to within 12 months (a possible 51.29% upside). 9 analyst firms have reported ratings in the last year.
Q
How much is Passage Bio (PASG) stock ?
A
The stock price for Passage Bio (NASDAQ: PASG) is $19.83 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Passage Bio (PASG) dividend?
A
There are no upcoming dividends for Passage Bio.
Q
When is Passage Bio (NASDAQ:PASG) reporting earnings?
A
Passage Bio’s Q1 earnings are confirmed from now on May 10, 2021.
Q
When is the upcoming split for PASG?
A
There is no upcoming split for Passage Bio.